Navigation Links
Researchers important markers of high risk of type 2 diabetes
Date:4/25/2008

Doctors are aware of a range of risk factors, mostly related to the patients family history, overweight, and lifestyle, that contribute to the risk of developing type 2 diabetes. Now researchers at the University of Warwick have found markers that indicate endothelial dysfunction (changes in the cells which line the blood vessels) and sub-clinical systemic inflammation can also help identify a far greater number of people at high risk for future development of type 2 diabetes.

In a study led by Dr Saverio Stranges, Associate Professor of Cardiovascular Epidemiology at Warwick Medical School at the University of Warwick, the team looked at a protein called E-selectin, whose presence is an indication of endothelial dysfunction, white blood cell count and levels of albumin, which are marker for sub-clinical systemic inflammation.

They found high levels of E-selectin and white blood cell count with low levels of serum albumin were clear predictors of high risk for type 2 diabetes. The researchers found that traditional risk factors such as obesity or family history helped identify 65% of all patients who were at high risk of developing type 2diabetes. But when the information from these three markers was added this increased from 65% to 73% which means doctors could be able to spot a greater number of people at risk of type 2 diabetes at an early stage.

The research used data taken from the Western New York Health Study. This was a six-year longitudinal study of diabetes and cardiovascular risk factors among residents of Erie and Niagara Counties, New York.

Dr Stranges said: "High levels of E-selectin and white blood cells with low levels of serum albumin can indicate endothelial dysfunction and sub-clinical systemic inflammation. These findings corroborate the notion that both these conditions play an important role in the development of the disease. Endothelial dysfunction is also regarded as a key event in the development and
'/>"/>

Contact: Peter Dunn
p.j.dunn@warwick.ac.uk
44-077-676-55860
University of Warwick
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Cancer researchers receive NIH grant to advance brain tumor therapies from lab to clinical trials
2. Researchers Identify Contaminant in Tainted Heparin
3. UMass Medical School researchers awarded pediatric HIV vaccine development grant
4. Researchers identify new cell targets for preventing growth of breast and other tumors
5. Melanoma lurks in larger skin lesions, NYU researchers find
6. Reduced Funds for Cancer is Cost of Iraq, Say Ex-White House Aide, Cancer Researchers
7. MU researchers reveal communication tactics used by sexual predators to entrap children
8. Penn researchers find potential in yeast for selecting Lou Gehrigs disease drugs
9. MU researchers find clue to cataract formation
10. Researchers evaluating food allergy treatment
11. U of M researchers identify process that may help treat Parkinsons, spinal cord injuries

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., NEW ORLEANS, Nov. 30 ... of the global corporation Sodexo will hold a rall...ies and Maintenance headquarters, 3800 Desire Park... policy and arbitrary disciplinary policies that t...r an ill family member. Sodexo employees who clean...
(Date:11/30/2009)... , LOS ANGELES, Nov. 30 /PRNewswi...ions, the Robert Wood Johnson Foundation Center fo...NM-RWJF Center), and impreMedia, shows a widesprea...out the importance of health care reform and indic.... For the first time, health care tops the list of...
(Date:11/30/2009)..., SCHAFFHAUSEN, Switzerland, Nov. 30 /PRNewswire-... ) today announced that its 2010 annual general me...arch 10, 2010 at 3:00 p.m. Central European time a...1, 8002 Zurich, Switzerland. Registered shareholde...e entitled to vote at the annual general meeting. ...
(Date:11/30/2009)..., GAINESVILLE, Fla., Nov. 30 The l...rks the availability of the first FDA-cleared, ful...n and analysis by a radiologist of suspicious brea...veiled at the Radiological Society of North Americ...in partnership with leading experts in breast MRI,...
(Date:11/30/2009)..., Ont., November 30, 2009 ― Providing free m...years to patients, lives at a relatively low cost ...dy by researchers at St. Michael,s Hospital in Tor...effective prescribed medications because they simp... Dhalla, the study,s lead author and a physician a...
Breaking Medicine News(10 mins):Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 3Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 4Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 5Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 6Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 7Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 8Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 9Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Coverage of inexpensive drugs may increase length and quality of life after heart attack 2
...erials made from metals and organic compounds is c...rials science just 10 years after its discovery, w... inflammable gases such as hydrogen and methane. ...ent research network, following a major workshop ...
...ore likely to be diagnosed with advanced cancers, ..., Feb. 18 (HealthDay News) -- People who either ha...e likely to be diagnosed with advanced cancers tha...no health insurance, the new study clearly shows t...
...Diagnostic Ultrasound Systems on Display, SHENZHE... Mindray,Medical International Limited (NYSE: MR ...of medical devices in China with a rapidly growing...Mindray,s president of international sales and mar...
...Tanning Setting an Exceptional Way to Promote ...IANAPOLIS, Feb. 18 Evidence of the critical role,...bility to prevent major,forms of cancer continues ...:, http://www.prnewswire.com/mnr/ets/27541/ , N...
...Strategic Focus on Late-Stage and Marketed ...nsylvania and OXFORD, England, February 18 /PRNews... specialty pharmaceutical,company focused on oncol...rleukin-6 antibody to GlaxoSmithKline,(GSK) for a ...
... the cognitive health of people, but now scientist...ng these learning and memory problems. A new Nati...rodents finds that increased levels of a stress ho...m memory. Moreover, when levels of the adrenal glu...
Other Medicine News:Health News:Novel organic metal hybrids that will revolutionize materials science and chemical engineering 2Health News:Timely Cancer Diagnosis Linked to Insurance Status 2Health News:Timely Cancer Diagnosis Linked to Insurance Status 3Health News:Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting 2Health News:Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting 3Health News:Video: Studies: Exposure to Ultraviolet Rays Best Way to Overcome Widespread Vitamin D Deficiency 2Health News:EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties 2Health News:EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties 3Health News:Stress hormone impacts memory, learning in diabetic rodents 2
(Date:11/30/2009)... , CHARLESTON, S.C., Nov. 30 ...um, "SEBIO 2009", will be held at the Charleston P... SC, on December 3-4, 2009. Dr. Cheryl Liljestran...patent attorneys with Stipkala LLC, will attend. ...ce companies, investors, scientists, entrepreneurs...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, Europ...lysis and Forecasts to 2015 ,, http://www.rep...nvestment-Opportunities-Analysis-and-Forecasts-to-...ent Opportunities, Analysis and Forecasts to 2015 ...
(Date:11/30/2009)... , COVINA, Calif., Nov. 30 St...mmercialization agreement with Academia Sinica, th...ietary methods and Intellectual Property (IP) rela...ells. This method and IP was pioneered by a team ...Academia Sinica. Professor Lin is currently the e...
Breaking Medicine Technology:Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3FDA approved leukemia drugs shows promise in ovarian cancer cells 10671 1FDA approved leukemia drugs shows promise in ovarian cancer cells 10671 2Teen Obesity Ups MS Risk in Women 61052 1Teen Obesity Ups MS Risk in Women 61052 2Teen Obesity Ups MS Risk in Women 61052 3Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 1Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 2Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 3Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 4Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 5Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 6Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 7Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 8Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 9Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 10Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 11Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 12Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 13Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 14Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 15Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 16Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 17Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 18Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 19Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 20Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 21Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 22Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 23Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 24Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 25Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 26Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 27Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 28Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 29Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 30Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 31Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 32Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 33
VACUETTE Paediatric EDTA Tubes - Non-ridged (pull cap)
VACUETTE EDTA tubes - Non-ridged (pull cap)
Lectora Authoring Software 2006
Anal Canal EMG Sensor
Medicine Products: